Literature DB >> 7127709

Invasive evaluation (coronary arteriography) of the coronary artery disease patient: clinical, economic and social issues.

D C Levin.   

Abstract

Radionuclide techniques have greatly enhanced noninvasive evaluation in the patient with suspected coronary artery disease (CAD). Although these techniques have high sensitivity and specificity, the published data contain significant inconsistencies and inaccuracies. Coronary arteriography remains the definitive method of determining the presence, site, severity and operability of CAD. Although the procedure is invasive, recent studies have shown that complication rates have been reduced to an acceptably low level, particularly in laboratories with extensive experience. The economic aspects of coronary arteriography are complex. Survey data acquired in early 1981 from 54 active cardiac catheterization laboratories around the country showed that the mean technical charge billed by the hospital for coronary angiographic procedures was $760 (range $307-1470). Analysis of the actual costs of the procedure to the hospital indicates that in most cases, these costs far exceed $760. Hospital budgeting practices in many states fail to create any incentive to match charges with costs. The mean professional fee billed by physicians for coronary arteriography was $640 (range $200-1200). An estimated 275,000 coronary arteriograms are performed annually in the United States, yielding a total cost of $577,500,000. Opportunities for significant cost cutting are limited, and seem to lie primarily in improving the utilization of existing laboratories that are underutilized. Unresolved economic, ethical and social issues pertaining to coronary arteriography include: centralizing the procedure in a smaller number of centers around the country; self-referral of patients for coronary arteriography; establishing training standards for coronary angiographers and performance standards for angiographic equipment; acceptable levels of sensitivity in noninvasive screening for suspected CAD; and utilization of coronary arteriography throughout the country.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7127709

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  7 in total

1.  Clinical feasibility of catheter-directed selective intracoronary computed tomography angiography using an extremely low dose of iodine in patients with coronary artery disease.

Authors:  Youngtaek Hong; Hyung-Bok Park; Byoung Kwon Lee; Seongmin Ha; Yeonggul Jang; Byunghwan Jeon; Sunghee Jung; Hackjoon Shim; Yang Soo Jang; Hyuk-Jae Chang
Journal:  Eur Radiol       Date:  2018-11-12       Impact factor: 5.315

2.  Patients with coronary stenosis and a fractional flow reserve of ≥0.75 measured in daily practice at the VU University Medical Center.

Authors:  N Oud; K M Marques; J G F Bronzwaer; S Brinckman; C P Allaart; C C de Cock; Y Appelman
Journal:  Neth Heart J       Date:  2010-09       Impact factor: 2.380

3.  Non-invasive intravenous coronary angiography using electron beam tomography and multislice computed tomography.

Authors:  A W Leber; A Knez; C Becker; A Becker; C White; C Thilo; M Reiser; R Haberl; G Steinbeck
Journal:  Heart       Date:  2003-06       Impact factor: 5.994

4.  A noninvasive method for coronary artery diseases diagnosis using a clinically-interpretable fuzzy rule-based system.

Authors:  Hamid Reza Marateb; Sobhan Goudarzi
Journal:  J Res Med Sci       Date:  2015-03       Impact factor: 1.852

5.  A milestone in prediction of the coronary artery dimensions from the multiple linear regression equation.

Authors:  A Divia Paul; S M Ashraf; J Ezhilan; S Vijayakumar; Anuj Kapadiya
Journal:  Indian Heart J       Date:  2019-08-06

6.  Coronary Angiography Using Noninvasive Imaging Techniques of Cardiac CT and MRI.

Authors:  Shun Kohsaka; Amgad N Makaryus
Journal:  Curr Cardiol Rev       Date:  2008-11

7.  Utility of nuclear stress imaging for detecting coronary artery bypass graft disease.

Authors:  Basel Al Aloul; Mackenzi Mbai; Selcuk Adabag; Santiago Garcia; Hoang Thai; Steven Goldman; William Holman; Gulshan Sethi; Rosemary Kelly; Herbert B Ward; Edward O McFalls
Journal:  BMC Cardiovasc Disord       Date:  2012-08-03       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.